Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-64730-2
Affiliations:
6
Authors:
17
Go to article
Institutions Authors Share
Yonsei University, South Korea
11.500000
11.500000
 0.68
National Cancer Center (NCC), South Korea
2.500000
 0.15
CoBX Bio, South Korea
1.000000
 0.06
Chung-Ang University (CAU), South Korea
1.000000
 0.06
Hospital of National Cancer Center, South Korea
0.500000
 0.03
Pohang University of Science and Technology (POSTECH), South Korea
0.500000
 0.03
Interested in Oncology and Carcinogenesis?